AAPL   367.34 (+0.89%)
MSFT   206.73 (+0.99%)
FB   234.30 (-1.37%)
GOOGL   1,465.00 (+1.60%)
AMZN   2,892.11 (+0.47%)
NVDA   385.77 (+1.20%)
CGC   16.42 (-0.30%)
MU   50.21 (+1.03%)
GE   6.89 (+2.23%)
TSLA   1,203.13 (+7.46%)
AMD   52.30 (-0.53%)
T   30.25 (+1.14%)
ACB   12.07 (-1.63%)
F   6.08 (+1.67%)
DIS   113.52 (+0.44%)
BAC   23.34 (+0.34%)
AAPL   367.34 (+0.89%)
MSFT   206.73 (+0.99%)
FB   234.30 (-1.37%)
GOOGL   1,465.00 (+1.60%)
AMZN   2,892.11 (+0.47%)
NVDA   385.77 (+1.20%)
CGC   16.42 (-0.30%)
MU   50.21 (+1.03%)
GE   6.89 (+2.23%)
TSLA   1,203.13 (+7.46%)
AMD   52.30 (-0.53%)
T   30.25 (+1.14%)
ACB   12.07 (-1.63%)
F   6.08 (+1.67%)
DIS   113.52 (+0.44%)
BAC   23.34 (+0.34%)
AAPL   367.34 (+0.89%)
MSFT   206.73 (+0.99%)
FB   234.30 (-1.37%)
GOOGL   1,465.00 (+1.60%)
AMZN   2,892.11 (+0.47%)
NVDA   385.77 (+1.20%)
CGC   16.42 (-0.30%)
MU   50.21 (+1.03%)
GE   6.89 (+2.23%)
TSLA   1,203.13 (+7.46%)
AMD   52.30 (-0.53%)
T   30.25 (+1.14%)
ACB   12.07 (-1.63%)
F   6.08 (+1.67%)
DIS   113.52 (+0.44%)
BAC   23.34 (+0.34%)
AAPL   367.34 (+0.89%)
MSFT   206.73 (+0.99%)
FB   234.30 (-1.37%)
GOOGL   1,465.00 (+1.60%)
AMZN   2,892.11 (+0.47%)
NVDA   385.77 (+1.20%)
CGC   16.42 (-0.30%)
MU   50.21 (+1.03%)
GE   6.89 (+2.23%)
TSLA   1,203.13 (+7.46%)
AMD   52.30 (-0.53%)
T   30.25 (+1.14%)
ACB   12.07 (-1.63%)
F   6.08 (+1.67%)
DIS   113.52 (+0.44%)
BAC   23.34 (+0.34%)
Log in

OTCMKTS:SAUHYSTRAUMANN HLDG/ADR Stock Price, Forecast & News

$45.40
+1.98 (+4.56 %)
(As of 07/2/2020 11:02 AM ET)
Add
Compare
Today's Range
$44.27
Now: $45.40
$45.40
50-Day Range
$34.30
MA: $40.38
$43.42
52-Week Range
$27.34
Now: $45.40
$53.72
Volume4,870 shs
Average Volume20,461 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Straumann Holding AG provides tooth replacement solutions worldwide. It researches, develops, manufactures, and supplies dental implants, instruments, biomaterials, CADCAM prosthetics, digital equipment, software, and clear aligners for applications in replacement, restorative, orthodontic, and preventative dentistry. The company offers dental implant systems, including tissue and bone level implant lines; ceramic, mini, and dental implant systems; and guided surgery and surgical instruments, as well as implant-borne prosthetics, such as tissue and bone level prosthetics. It also provides biomaterials, bone substitutes, membranes, biologics, and soft tissue management and oral healing products; digital solutions for dental labs, dentists, and centralized milling centers, as well as materials, third party systems, and guided surgery; surgical instruments comprising surgical cassettes, guided instruments, implant maintenance products, bone block fixation sets, bonerings, titanium pin sets, and other cassettes; and edentulous, pro arch fixed, prosthetic, and mini implant solutions for edentulous patients. In addition, the company offers esthetic restorations that include ceramic implant monotypes, ceramic implants, abutments, 3D-soft tissue grafts, biologics, and other solutions; Roxolid for use in implant dentistry; SLActive implants; Endogain for wound healing; and short and bone level tapered implants. Further, it provides Neodent systems; Medentika solutions; Equinox dental implant systems; Clear Correct aligners; and training and education services to its customers. The company offers its products to general dentists, specialists, and dental technicians/laboratories, as well as corporate customers, such as dental chains, distributors, hospitals, and university clinics in approximately 100 countries through a network of distribution subsidiaries and partners. Straumann Holding AG was founded in 1954 and is headquartered in Basel, Switzerland.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.42 out of 5 stars


Industry, Sector and Symbol

Industry Medical Instruments & Supplies
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:SAUHY
CUSIPN/A
CIKN/A
Phone41 61 965 11 11

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees5,716
Next Earnings DateN/A
OptionableNot Optionable

Receive SAUHY News and Ratings via Email

Sign-up to receive the latest news and ratings for SAUHY and its competitors with MarketBeat's FREE daily newsletter.

STRAUMANN HLDG/ADR (OTCMKTS:SAUHY) Frequently Asked Questions

How has STRAUMANN HLDG/ADR's stock been impacted by COVID-19 (Coronavirus)?

STRAUMANN HLDG/ADR's stock was trading at $40.45 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, SAUHY stock has increased by 12.2% and is now trading at $45.40. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of STRAUMANN HLDG/ADR?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for STRAUMANN HLDG/ADR in the last year. There are currently 3 sell ratings, 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for STRAUMANN HLDG/ADR.

Has STRAUMANN HLDG/ADR been receiving favorable news coverage?

Media headlines about SAUHY stock have been trending very negative this week, InfoTrie Sentiment reports. InfoTrie scores the sentiment of press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. STRAUMANN HLDG/ADR earned a news impact score of -3.3 on InfoTrie's scale. They also gave news articles about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View the latest news about STRAUMANN HLDG/ADR.

Who are some of STRAUMANN HLDG/ADR's key competitors?

Who are STRAUMANN HLDG/ADR's key executives?

STRAUMANN HLDG/ADR's management team includes the following people:
  • Mr. Marco Gadola, CEO & Member of Exec. Management Board (Age 56)
  • Dr. Sebastian Burckhardt, Sec. of the Board & Director (Age 65)
  • Dr. Peter Hackel, CFO & Member of Exec. Management Board (Age 50)
  • Mr. Wolfgang Becker, Head of Distributor & Emerging Markets - EMEA and Member of Exec. Management Board (Age 53)
  • Mr. Frank Hemm, Head of Marketing & Education and Member of Exec. Management Board (Age 49)

What is STRAUMANN HLDG/ADR's stock symbol?

STRAUMANN HLDG/ADR trades on the OTCMKTS under the ticker symbol "SAUHY."

How do I buy shares of STRAUMANN HLDG/ADR?

Shares of SAUHY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is STRAUMANN HLDG/ADR's stock price today?

One share of SAUHY stock can currently be purchased for approximately $45.40.

What is STRAUMANN HLDG/ADR's official website?

The official website for STRAUMANN HLDG/ADR is www.straumann.com.

How can I contact STRAUMANN HLDG/ADR?

The company can be reached via phone at 41 61 965 11 11.

This page was last updated on 7/2/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.